Venture capital firm based in Glasgow, UK
Glox Therapeutics secures £4.3 million in seed funding to revolutionize antimicrobial therapy by developing precision antibiotics that combat antibiotic-resistant Gram-negative bacteria, backed by Boehringer Ingelheim Venture Fund and Scottish Enterprise. Read more
Scottish art tech startup, sellmyartworks.com, secures £300K in funding to launch upscale resale platforms, revolutionizing the art market with a seamless and trustworthy online marketplace. Read more
Bright Ascension secures £2.25M in funding to accelerate the release of innovative space software products, backed by notable investors like Scottish Enterprise and Capital for Colleagues. Read more
Edinburgh insect genetics company, Beta Bugs, secures £1.72M funding to expand production and supply of sustainable Black Soldier Fly eggs and larvae, offering a green solution to deforestation and overfishing. Read more
Edinburgh's Carbogenics secures nearly £500K to fuel its pioneering biochar technology, aiming to revolutionize waste management and combat climate change with innovative products like CreChar® and FilaChar®. Read more
Edinburgh-based Carcinotech secures £4.2m funding to advance revolutionary 3D printed micro-tumour technology, revolutionizing drug screening and improving cancer treatment. Read more
Glasgow-based diagnostics company, Microplate Dx, secures £2.5M in Seed funding to develop its point-of-care diagnostic platform that rapidly identifies effective antibiotics for bacterial infections, starting with urinary tract infections (UTIs). Read more
BDD Pharma secures £2M funding to accelerate expansion of its drug formulation and clinical trial services, propelled by its patented oral drug delivery technology OralogiK™. Read more
Healthtech | 76.9% |
Marketplace | 7.7% |
SaaS | 7.7% |
AI | 7.7% |